2. We are catalysts for innovation, helping facilitate
change across whole health and social care
economies – to improve health, drive down the
cost of care, and stimulate economic growth.
Drive down the cost of care Stimulate economic growthImprove health
INNOVATION Exchange Network
3. England’s 15 AHSNs operate as the
innovation arm of the NHS
INNOVATION Exchange Network
4. 1. Engagement and buy-in
2. Culture – different professional groups, perspectives and beliefs
3. Multiple organisations involved in decisions – integrating services
4. Silo working
5. Sourcing the right solutions - how do we know what we don’t know?
6. Resources
7. Managing and leading change
Innovation Agency is here to help build capability in the system, connecting you to
solutions and support overcoming barriers to spread
Build an innovation mind-set into job roles and everyday practice
INNOVATION Exchange Network
7. INNOVATION Exchange Network
To create a network of interest across the system for the uptake of
innovation
Act as a conduit for the sharing of existing innovative practice and
support spread to elsewhere in the system
Create a system level pipeline for innovation identification and spread
Testing solutions with real world validation
Identify the system needs and priorities and curate solutions
Match innovations to mobilise transformational and improvement
strategies of your Trust/CCG/Place e.g. new models of care
9. Cheshire and Merseyside team:
Jenny Dodd
Sue Critchley
Ed Millensted
Lancashire and South Cumbria:
Eleanor Garnett-Bentley
Gemma Byrne
Howerd Booth
INNOVATION Exchange Network
10. INNOVATION Exchange Network
Support system transformation through the adoption of innovations that
enhance quality and value:
• Structured working with the Health and Care Partnership/L&SC
• Links with strategic transformational programmes and places
• Trust engagement visits and other networks
• Spread of nationally commissioned products & programmes
• Pathway transformation at a system level e.g troponin, urolift, TCAM,
ELC
11. Mapping and navigating the health & care landscape
Classify our products into solution categories that reflect the
health & care sector
Hold conversations with providers to understand service
needs and priorities
Match innovative solutions to identified needs
Navigating the footprint and signposting companies
INNOVATION Exchange Network
12. We have simplified access to a wide range of tools, practices and
innovations by grouping them into eight solution categories.
Patient activation and
self-care
Patient safety and quality
improvement
Greater support and resource
for primary care
Workforce resource
optimisation
Digitalising the
system
Improving system
flow
Independence and
prevention
Operational
excellence
14. The Coaching Academy is the vehicle for the education,
learning and development programmes offered by the
Innovation Agency
We exist to:
Increase capabilities for spread and adoption
Support regional programmes for system integration
Transform system culture for safety, innovation and
improvement
Collaborate with agencies to align support
Build internal capabilities for a thriving workplace
INNOVATION Exchange Network
19. • Innovation Technology
Tariff (ITT)
• Innovation and Technology
Payment (ITP)
• Accelerated Access
Collaborative (AAC)
HST
UroLift
PCSK9i
PLGF
FIT
Epi-
Scissors
NIC
Endo-
Cuff
Heartflow
Cladribine
Gamma
core
Space
OAR
PneuX
Secur
Acath
Calprotectin
FMT
MyCOPD
20. HeartFlow
FFRCT
• A standard coronary CT scan is uploaded to
HeartFlow, which produces an FFRCT, and a 3D
model of the coronary arteries. Reduces
unnecessary invasive angiograms by specifically
identifying site and degree of coronary artery block
High sensitivity
troponin- T
assay
PCSK9 • For people at high risk of heart disease who do
not reach target cholesterol levels using
traditional medicines.
• Two blood tests are performed 1 or 3 hours apart
compared to standard testing (10-12 hours apart), to
rule out myocardial infarction within four hours of
presentation to the emergency department (ED).
Cardiology
Cardiology
Cardiology,
diabetology,
endocrinology,
clinical biochemistry
21. Episcissors
PLGF ratio test &
triage test
• Blood test to measure the ratio of protein
biomarkers detectable before the onset of pre-
eclampsia.
• Or point of care blood test result within 20 minutes
to measure elevation of one protein biomarker
detectable before the onset of pre-eclampsia.
• Fixed 60o scissors to increase accuracy of the
episiotomy angle.
• Reduces risk of damage to the pelvic floor and the
need for further surgery.
Women and
children’s
Women and
children’s
22. Urolift
• Hydrogel injected between the prostate and
rectum prior to prostate radiotherapy,
temporarily creates space between them.
Minimises radiation dose to the rectum and
other organs, reducing radium toxicity and its
complications.
Space OAR
Hydrogel
• Day case procedure to relieve symptoms of
urinary outflow obstruction without cutting or
removing tissue. A cost-effective alternative
to TURP, reducing theatre costs, outpatient
activity and improving patient satisfaction.
Urology
Urology,
oncology,
radiotherapy
23. Cladribine
• A tablet for rapidly evolving severe
relapsing remitting Multiple Sclerosis (MS).
Reduces relapse by 58% and risk of
disability by 33%
• Patient-handheld medical device that
enables self-administering discrete doses of
non-invasive vagus nerve stimulation
therapy for the treatment of cluster
headache.
gammaCore
Neurology
Neurology
24. Non injectable
connector (NIC)
• A one-way valve that attaches to an arterial line,
allowing blood gas sampling but not drug
administration.
• Prevents serious error, reduces risk of blood
spillage and bacterial contamination
• Subcutaneous catheter stabilization device with
small nickel feet placed just beneath the skin at
the insertion site. Reduces need for adhesive
dressings, cleaning time and dislodgement rates.
SecurAcath
Intensive care,
coronary care
ITP
25. • A silicone cuffed endotracheal tube with an
electronic cuff monitoring and inflating device.
Prevents leakage of bacteria contaminated
secretions to the lung, lowering the rate of ventilator
associated pneumonia by 50%.
• Education, assessment, self-management,
symptom reporting and pulmonary rehab app. It
enables clinician remote monitoring, self-
management and reduces hospital admissions.
myCOPD
PneuX
ITT
ITT
26. Faecal
Microbiota
Transplant
• Treats recurrent clostridium difficile bacterial infections
in one dose with 80% efficacy, reducing unnecessary
antibiotic therapy and mortality.
Faecal
Immuno
Chemical Test
• Self-administered postal stool sample to detect
faecal occult blood. Better than traditional tests for
early detection of colorectal cancer and helps detect
other colorectal abnormalities
Gastroenterology,
endoscopy, biochemistry
Gastroenterology,
endoscopy, biochemistry
27. Faecal
Calprotectin
• Self-administered stool test to detect increased levels of
calprotectin. Distinguishes between inflammatory and
non-inflammatory syndromes, allowing early effective
management and reducing unnecessary colonoscopies.
Endocuff
Vision
• Small, soft device attached to the distal end of a
colonoscope, designed to maintain and maximize the
viewable mucosa during endoscopy
• ↑ Adenoma Detection Rate by 4.7%
Primary care,
gastroenterology,
endoscopy,
biochemistry
Gastroenterology,
endoscopy, general
surgery
Patient activation and self-care
Products and services that:
• Support people with an existing diagnosis to manage their condition
• Use of support and education to increase patient activation that will reduce likelihood of exacerbation
• Provide information and advice which helps people maximise their wellbeing
Patient safety and quality improvement
Products and services that:
• Increase the quality and safety of clinical services
• Reduce impacts of human factors
• Reduce serious incidents and never events
• Improve patient experience
• Improves outcomes and reduce side effects
Greater support and resource for primary care
Products and services that:
• Release GP capacity
• Make GP practices more effective and efficient places to work
Digitalising the system
Products and services that:
• Trigger a shift from paper based working to digital working
• Introduce remote and assistive technology
• Enable record sharing and interoperability
• Population-based intelligence systems
• Increase patient access to information and records
• Reduce the burden of travel for staff and patients
Independence and prevention
Products and services that:
• Improve the physical, mental and emotional wellbeing of individuals and carers
• Are targeted at healthy people to keep them well and prevent illness
• Support early diagnosis by identifying people at risk of developing disease
• Identify people with an existing diagnosis to who are at risk of deterioration
Improving system flow
Products and services that:
• Reduce time spent in hospital
• Help navigation of the urgent care system to prevent admissions
• Reduce delayed transfers of care
• Identify bed availability across the system
• Reduce time lost waiting for access and discharge
55% angiograms are unnecessary and do not result in a change of management. It is not as accurate as HeartFlow
15 AHSN
We do spread and adoption
First time in NHS history this has been attempted at scale